$ETBI is an emerging pharmaceutical company exploring drug delivery innovations for the development of novel formulations and alternative dosage forms of existing biologically active molecules. The company recently expanded its new pharmaceutical product development to include large molecules as active compounds that will address indications in diabetes, obesity and the overall metabolic syndrome.